Company intelligence / Profile preview

Arcadophta

Ownership: Private
Development stage: Other

Overview

Arcadophta is a France‑based ophthalmic company specializing in silicone oils, intraocular gases, and perfluorocarbon liquids used as vitreous tamponades and surgical fluids in vitreoretinal surgery; its commercial product line and ~25 years of expertise were acquired by BVI in Q4 2019.[4][3][6]

Therapeutic areas: Ophthalmology
Modalities: Device
Industry: Surgical Medical Devices

Partnerships

BVI (integration and global commercialization of Arcad product line)[4][3]

Beyond the preview

Go deeper on Arcadophta.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arcadophta.

Explore the full profile